Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis

Targeted Versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients

(2014) G. A. Eschenauer et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Randomized, Double-Blind Trial of Anidulafungin Versus Fluconazole for Prophylaxis of Invasive Fungal Infections in High-Risk Liver Transplant Recipients

(2014) D.J. Winston et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Antifungal Prophylaxis in Liver Transplantation: A Systematic Review and Network Meta-Analysis

(2014) J. D. W. Evans et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Invasive fungal infections in solid organ transplant recipients

(2014) J. Gavaldà et al.   CLINICAL MICROBIOLOGY AND INFECTION

Fungal infection in patients after liver transplantation in years 2003 to 2012

(2013) Xiang-Dong Guan   Annals of Transplantation

Micafungin Versus Amphotericin B Lipid Complex for the Prevention of Invasive Fungal Infections in High-Risk Liver Transplant Recipients

(2013) Hsin-Yun Sun et al.   TRANSPLANTATION

Invasive fungal infections following liver transplantation: Incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007)

(2012) Anupama Raghuram et al.   LIVER TRANSPLANTATION

Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients

(2012) Faouzi Saliba et al.   MEDICAL MYCOLOGY

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

(2011) Peter C. Austin   MULTIVARIATE BEHAVIORAL RESEARCH

Universal Prophylaxis With Fluconazole for the Prevention of Early Invasive Fungal Infection in Low-Risk Liver Transplant Recipients

(2011) Rafael San-Juan et al.   TRANSPLANTATION

Antifungal Management Practices in Liver Transplant Recipients

(2010) N. Singh et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Systematic Review and Meta-Analysis of the Tolerability and Hepatotoxicity of Antifungals in Empirical and Definitive Therapy for Invasive Fungal Infection

(2010) J. L. Wang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study

(2010) M. Winkler et al.   Transplant Infectious Disease

Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients

(2010) D. Neofytos et al.   Transplant Infectious Disease

Propensity Score Methods

(2009) Donald B. Rubin   AMERICAN JOURNAL OF OPHTHALMOLOGY

Candidain Solid Organ Transplant Recipients

(2009) P. G. Pappas et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Prophylaxis With Caspofungin for Invasive Fungal Infections in High-Risk Liver Transplant Recipients

(2009) Jesus Fortún et al.   TRANSPLANTATION

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES